Cargando…
Development of Nanoparticles Incorporating a Novel Liposomal Membrane Destabilization Peptide for Efficient Release of Cargos into Cancer Cells
In anti-cancer therapy mediated by a nanoparticle-based drug delivery system (DDS), overall efficacy depends on the release efficiency of cargos from the nanoparticles in the cancer cells as well as the specificity of delivery to tumor tissue. However, conventional liposome-based DDS have no mechani...
Autores principales: | Itakura, Shoko, Hama, Susumu, Ohgita, Takashi, Kogure, Kentaro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4208851/ https://www.ncbi.nlm.nih.gov/pubmed/25343714 http://dx.doi.org/10.1371/journal.pone.0111181 |
Ejemplares similares
-
Rapid modification of antibodies on the surface of liposomes composed of high-affinity protein A-conjugated phospholipid for selective drug delivery
por: Hama, Susumu, et al.
Publicado: (2021) -
Lipocalin2 as a plasma marker for tumors with hypoxic regions
por: Nakamura, Ibuki, et al.
Publicado: (2014) -
The novel functional nucleic acid iRed effectively regulates target genes following cytoplasmic delivery by faint electric treatment
por: Hasan, Mahadi, et al.
Publicado: (2016) -
Intraperitoneal administration of nanoparticles containing tocopheryl succinate prevents peritoneal dissemination
por: Hama, Susumu, et al.
Publicado: (2022) -
DNA–Liposome
Hybrid Carriers for Triggered
Cargo Release
por: Baumann, Kevin N., et al.
Publicado: (2022)